NIH Guide: Weekly Index for November 22, 2024

Funding Opportunities

• NICHD Small Research Grant Program (R03 Clinical Trial Required)
  (PA-25-125)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): Multiple dates, see announcement.
• NICHD Small Research Grant Program (R03 Basic Experimental Studies with Humans Required)
  (PA-25-126)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): Multiple dates, see announcement.
• Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R21 Clinical Trial Not Allowed)
  (PA-25-173)
  National Cancer Institute
  Application Receipt Date(s): February 16, 2025 *
• Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R01 Clinical Trial Not Allowed)
  (PA-25-174)
  National Cancer Institute
  Application Receipt Date(s): February 05, 2025
• Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research (R03 Clinical Trial Optional)
  (PA-25-246)
  National Institute on Aging
  Application Receipt Date(s): Multiple dates, see announcement.
• Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R01 Clinical Trial Optional)
  (PA-25-294)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R21 Clinical Trial Optional)
  (PA-25-295)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Aging Research Dissertation Awards to Promote Diversity (R36 Clinical Trial Not Allowed)
  (PAR-24-130)
  National Institute on Aging
  Application Receipt Date(s): Multiple dates, see announcement.
• NEI Postbaccalaureate Opportunities in Vision Science (POVS) Research Education Program (R25 Clinical Trial Not Allowed)
  (PAR-24-290)
  National Eye Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Independent Clinical Trial Not Allowed)
  (PAR-24-316)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Novel Assays to Address Translational Gaps in Treatment Development (UG3/UH3 Clinical Trial Optional)
  (PAR-25-034)
  National Institute of Mental Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Building in vivo Preclinical Assays of Circuit Engagement for Application in Therapeutic Development (R01 Clinical Trial Not Allowed)
  (PAR-25-035)
  National Institute of Mental Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Cellular and Molecular Biology of Complex Brain Disorders (R21 Clinical Trial Not Allowed)
  (PAR-25-037)
  National Institute of Mental Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Cellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed)
  (PAR-25-038)
  National Institute of Mental Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional)
  (PAR-25-039)
  National Institute of Mental Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)
  (PAR-25-040)
  National Institute of Mental Health
  Application Receipt Date(s): Multiple dates, see announcement.
• NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional)
  (PAR-25-052)
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): Multiple dates, see announcement.
• Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional)
  (PAR-25-064)
  National Institute of Mental Health
  National Institute on Aging
  Application Receipt Date(s): Multiple dates, see announcement.
• Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional)
  (PAR-25-065)
  National Institute of Mental Health
  National Institute on Aging
  Application Receipt Date(s): Multiple dates, see announcement.
• Social disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional)
  (PAR-25-066)
  National Institute of Mental Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional)
  (PAR-25-067)
  National Institute of Mental Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)
  (PAR-25-069)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
  (PAR-25-070)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Pragmatic Trials across the Cancer Control Continuum (UG3/UH3 Clinical Trial Required)
  (PAR-25-072)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Advancing Research Careers (ARC) Predoctoral to Postdoctoral Transition Award to Promote Broad Participation (F99/K00 - Clinical Trial Not Allowed)
  (PAR-25-084)
  National Institute of General Medical Sciences
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Library of Medicine
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  Application Receipt Date(s): Multiple dates, see announcement.
• Archiving and Documenting Child Health and Human Development Data Sets (R03 Clinical Trial Not Allowed)
  (PAR-25-092)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): Multiple dates, see announcement.
• Impacts of climate change across the cancer control continuum (R01 Clinical Trial Optional)
  (PAR-25-094)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
  (PAR-25-095)
  National Cancer Institute
  National Institute on Aging
  National Institute of Dental and Craniofacial Research
  National Human Genome Research Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
  (PAR-25-096)
  National Cancer Institute
  National Institute on Aging
  National Institute of Dental and Craniofacial Research
  National Human Genome Research Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• NIDCR Small Grant Program for New Investigators (R03 Clinical Trial Not Allowed)
  (PAR-25-105)
  National Institute of Dental and Craniofacial Research
  Application Receipt Date(s): Multiple dates, see announcement.
• Small Research Grants for Analyses of Gabriella Miller Kids First Pediatric Research Data (R03 Clinical Trial Not Allowed)
  (PAR-25-109)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Cancer Institute
  National Institute of Dental and Craniofacial Research
  Application Receipt Date(s): Multiple dates, see announcement.
• Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional)
  (PAR-25-110)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Allergy and Infectious Diseases
  National Institute on Drug Abuse
  National Institute of Mental Health
  Office of Research on Women's Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)
  (PAR-25-111)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Allergy and Infectious Diseases
  National Institute on Drug Abuse
  Office of Research on Women's Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Advancement and Innovation in Measurement of Language Development and Predictors (R01 Clinical Trial Not Allowed)
  (PAR-25-112)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Deafness and Other Communication Disorders
  Application Receipt Date(s): Multiple dates, see announcement.
• Advancement and Innovation in Measurement of Language Development and Predictors (R21 Clinical Trial Not Allowed)
  (PAR-25-113)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Deafness and Other Communication Disorders
  Application Receipt Date(s): Multiple dates, see announcement.
• NCMRR Early Career Research Award (R03 Clinical Trial Optional)
  (PAR-25-124)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): Multiple dates, see announcement.
• Biology of Bladder Cancer (R21 Clinical Trial Optional)
  (PAR-25-128)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Biology of Bladder Cancer (R01 Clinical Trial Optional)
  (PAR-25-129)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• NCI Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed)
  (PAR-25-135)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
  (PAR-25-148)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Eye Institute
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute of Mental Health
  National Institute of Nursing Research
  Application Receipt Date(s): Multiple dates, see announcement.
• Impacts of climate change across the cancer control continuum (R21 Clinical Trial Optional)
  (PAR-25-152)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• NIDCR Research Grants for Analyses of Existing Genomics Data (R01) (Clinical Trial Not Allowed)
  (PAR-25-164)
  National Institute of Dental and Craniofacial Research
  Application Receipt Date(s): Multiple dates, see announcement.
• NIDCR Small Research Grants for Analyses of Existing Genomics Data (R03 Clinical Trial Not Allowed)
  (PAR-25-166)
  National Institute of Dental and Craniofacial Research
  Application Receipt Date(s): Multiple dates, see announcement.
• Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional)
  (PAR-25-171)
  National Cancer Institute
  Application Receipt Date(s): February 05, 2025 *
• Limited Competition: Small Grant Program for ORIP Special Emphasis Research Career Award (SERCA) K01 Recipients (R03 Clinical Trial Not Allowed)
  (PAR-25-176)
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  Application Receipt Date(s): Multiple dates, see announcement.
• NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed)
  (PAR-25-204)
  National Institute on Drug Abuse
  Application Receipt Date(s): Multiple dates, see announcement.
• Information and Practice Needs Relevant to Late Talking Children (R21 Clinical Trial Not Allowed)
  (PAR-25-217)
  National Institute on Deafness and Other Communication Disorders
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Center for Advancing Translational Sciences
  National Center for Advancing Translational Sciences
  Application Receipt Date(s): Multiple dates, see announcement.
• Leveraging Extant Data to Understand Developmental Trajectories of Late Talking Children (R21 Clinical Trial Not Allowed)
  (PAR-25-220)
  National Institute on Deafness and Other Communication Disorders
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Mental Health
  National Center for Advancing Translational Sciences
  National Center for Advancing Translational Sciences
  Application Receipt Date(s): Multiple dates, see announcement.
• Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)
  (PAR-25-226)
  National Institute on Aging
  Application Receipt Date(s): Multiple dates, see announcement.
• Investigator Initiated Innovation in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)
  (PAR-25-228)
  National Human Genome Research Institute
  National Library of Medicine
  Application Receipt Date(s): Multiple dates, see announcement.
• Investigator Initiated Innovation in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)
  (PAR-25-229)
  National Human Genome Research Institute
  National Library of Medicine
  Application Receipt Date(s): Multiple dates, see announcement.
• Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed)
  (PAR-25-243)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)
  (PAR-25-244)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)
  (PAR-25-248)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required)
  (PAR-25-254)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• NIDA Avant-Garde Program for HIV and Substance Use Disorder Research (DP1 Clinical Trial Optional)
  (PAR-25-261)
  National Institute on Drug Abuse
  Application Receipt Date(s): Not Applicable
• NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required)
  (PAR-25-267)
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)
  (PAR-25-268)
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)
  (PAR-25-274)
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Research Opportunities in Established Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)
  (PAR-25-275)
  National Cancer Institute
  Application Receipt Date(s): February 28, 2025
• Advancing Learning Health Care Research in Outpatient Mental Health Treatment Settings (R34 Clinical Trial Optional)
  (PAR-25-278)
  National Institute of Mental Health
  National Institute on Drug Abuse
  Application Receipt Date(s): Multiple dates, see announcement.
• Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional)
  (PAR-25-281)
  National Institute of Mental Health
  Office of Research on Women's Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional)
  (PAR-25-282)
  National Institute of Mental Health
  Office of Research on Women's Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Not Allowed)
  (PAR-25-286)
  National Institute of Mental Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R01 Clinical Trial Not Allowed)
  (PAR-25-287)
  National Institute of Mental Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R01 Clinical Trial Optional)
  (PAR-25-290)
  National Institute of Mental Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21 Clinical Trial Optional)
  (PAR-25-291)
  National Institute of Mental Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Screening, Brief Intervention and Referral to Treatment or Prevention (SBIRT/P) for alcohol, tobacco, and other drugs (ATOD) use and misuse in adult populations that experience health disparities (R01, Clinical Trial Required)
  (PAR-26-001)
  Office of Disease Prevention
  National Institute on Alcohol Abuse and Alcoholism
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  Office of Research on Women's Health
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): Multiple dates, see announcement.
• Advancing Translation of Long-Acting Strategies for HIV and HIV-Associated Co-infections (AT LASt) (R61/R33 Clinical Trial Not Allowed)
  (RFA-AI-24-076)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): Not Applicable
• Medical Devices for Pediatric Population Affected by Substance Use and Addiction (R43 - Clinical Trials Optional)
  (RFA-DA-26-016)
  National Institute on Drug Abuse
  Application Receipt Date(s): February 26, 2025
• Medical Devices for Pediatric Population Affected by Substance Use and Addiction (R41 - Clinical Trials Optional)
  (RFA-DA-26-017)
  National Institute on Drug Abuse
  Application Receipt Date(s): February 26, 2025
• Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)
  (RFA-DA-26-034)
  National Institute on Drug Abuse
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): Multiple dates, see announcement.
• Contraceptive Development Research Centers (P50 Clinical Trial Optional)
  (RFA-HD-26-004)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): November 12, 2025
• Advancing Genomic Medicine Research (R01 Clinical Trial Optional)
  (RFA-HG-25-002)
  National Human Genome Research Institute
  National Cancer Institute
  Application Receipt Date(s): February 11, 2025
• Advancing Genomic Medicine Research (R21 Clinical Trial Optional)
  (RFA-HG-25-003)
  National Human Genome Research Institute
  National Cancer Institute
  Application Receipt Date(s): February 11, 2025
• Advancing Genomic Medicine Research (R03 Clinical Trial Not Allowed)
  (RFA-HG-25-004)
  National Human Genome Research Institute
  Application Receipt Date(s): February 11, 2025
• Enhancing Reuse of NHGRI Data Assets (R03 Clinical Trial Not Allowed)
  (RFA-HG-25-005)
  National Human Genome Research Institute
  Application Receipt Date(s): February 13, 2025; February 13, 2026
• NHLBI SBIR Phase IIB Bridge Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional)
  (RFA-HL-26-014)
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): Not Applicable
• NHLBI SBIR Phase IIB Small Market Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional)
  (RFA-HL-26-015)
  National Heart, Lung, and Blood Institute
  National Center for Advancing Translational Sciences
  National Center for Advancing Translational Sciences
  Application Receipt Date(s): Not Applicable
• Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed)
  (RFA-HL-26-016)
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)
  (RFA-HL-26-017)
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 - Clinical Trial Not Allowed)
  (RFA-HL-26-018)
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Catalyze Product Definition Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed)
  (RFA-HL-26-019)
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Catalyze: Product Definition Medical Device Prototype Optimization (R33 - Clinical Trial Not Allowed)
  (RFA-HL-26-020)
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Role of T-Cells in HIV CNS Reservoir Seeding, Persistence, and Neuropathogenesis (R01 Clinical Trial Not Allowed)
  (RFA-MH-26-110)
  National Institute of Mental Health
  National Institute on Drug Abuse
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): Not Applicable
• Role of T-Cells in HIV CNS Reservoir Seeding, Persistence, and Neuropathogenesis (R21 Clinical Trial Not Allowed)
  (RFA-MH-26-111)
  National Institute of Mental Health
  National Institute on Drug Abuse
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): Not Applicable
• NINR Resources and Related Research Projects in Firearm Injury Prevention (R24 Clinical Trial Not Allowed)
  (RFA-NR-25-002)
  National Institute of Nursing Research
  Office of Research on Women's Health
  Office of Disease Prevention
  Application Receipt Date(s): January 28, 2025
• BRAIN Initiative: Promoting Equity Through BRAIN Technology Partnerships (R34 - Clinical Trials Not Allowed)
  (RFA-NS-25-016)
  National Institute of Neurological Disorders and Stroke
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Mental Health
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  Office of Behavioral and Social Sciences Research
  Application Receipt Date(s): Multiple dates, see announcement.
• Limited Competition: NIH Neuroscience Doctoral Readiness Program (DR. Program) (R25 Clinical Trial Not Allowed)
  (RFA-NS-25-027)
  National Institute of Neurological Disorders and Stroke
  National Institute on Drug Abuse
  Application Receipt Date(s): March 25, 2025
• Occupational Safety and Health Training Project Grants [T03]
  (RFA-OH-25-003)
  National Institute for Occupational Safety and Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Limited Competition: Competing Revisions to Support Clinical Trials in Somatic Cell Genome Editing (U19 Clinical Trial Required)
  (RFA-RM-24-008)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): Not Applicable